Sandoz, on a $1.1B investment spree in Slovenia, breaks ground at new $440M biosimilar plant
  Company issues nationwide recall for this antibiotic injction
  Swiss pharma firm Sandoz invests $440 million in Slovenia
  Sandoz Further Asserts Leadership In Biosimilars, Breaking Ground On New Slovenia Facility To Expand European Biosimilar Hub And Global Market Reach
  Sandoz Recalls Cefazolin Due to Mispackaging, Opens Biosimilar Facility in Slovenia
  Sandoz breaking ground on new Slovenia biosimilars facility
  Lek starts works on 400 mln euro biosimilars plant in Brnik
  Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Cefazolin for Injection Due to Product Mispackaging